Literature DB >> 2537800

Serological markers of hepatitis B virus and hepatitis D virus infections in Greek adults with primary hepatocellular carcinoma.

N C Tassopoulos1, G Theodoropoulos, M H Sjogren, R Engle, R H Purcell.   

Abstract

Primary hepatocellular carcinoma (PHC) has been linked etiologically to chronic hepatitis B virus (HBV) infection by epidemiologic and molecular lines of evidence. Serologic evidence of HBV and hepatitis delta virus (HDV) infection was assessed in sera from 47 Greek patients with PHC. Radioimmunoassays for the detection of serological markers of HBV and HDV infections and molecular hybridization techniques for the detection of HBV DNA sequences were used. Serological evidence of HBV infection was found in 93.6% of PHC patients. Of the 47 patients, 20 (42.6%) were positive for HBsAg, 43 (91.5%) were positive for anti-HBc and 21 (44.7%) were positive for anti-HBs. Anti-HBe was detected in a high percentage (90%) of HBsAg positive PHC patients. Anti-HBc IgM was also detected in 90% of HBsAg positive PHC patients; in contrast, HBV DNA was detected only in 5% of them. None of the 47 patients had serological evidence of HDV infection. These data show that HBV appears to be the principal etiological agent of PHC in Greece.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2537800     DOI: 10.1007/bf01643493

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  26 in total

1.  Search for hepatitis B virus DNA in sera from patients with acute type B or non-A, non-B hepatitis.

Authors:  N C Tassopoulos; G J Papaevangelou; A Roumeliotou-Karayannis; J R Ticehurst; S M Feinstone; R H Purcell
Journal:  J Hepatol       Date:  1986       Impact factor: 25.083

2.  Delta infection in hepatocellular carcinoma positive for hepatitis B surface antigen.

Authors:  G Raimondo; A Craxi; G Longo; G Giannuoli; M Caltagirone; M Aragona; G Pecoraro; G Squadrito; L Pagliaro
Journal:  Ann Intern Med       Date:  1984-09       Impact factor: 25.391

3.  Hepatitis B viral markers in patients with chronic hepatitis and with primary hepatocellular carcinoma in Taiwan.

Authors:  M J Tong; M C Chien; K J Lo; Y T Tsai; J K Lee
Journal:  Prog Med Virol       Date:  1981

4.  Delta agent infection in patients with chronic liver diseases and hepatocellular carcinoma--an infrequent finding in Taiwan.

Authors:  D S Chen; M Y Lai; J L Sung
Journal:  Hepatology       Date:  1984 May-Jun       Impact factor: 17.425

5.  Diagnostic value of anti-HBc IgM in high HBV prevalence areas.

Authors:  G Papaevangelou; A Roumeliotou-Karayannis; N Tassopoulos; P Stathopoulou
Journal:  J Med Virol       Date:  1984       Impact factor: 2.327

6.  Prevalence of delta antigen/antibody in B-viral-associated hepatocellular carcinoma.

Authors:  S Govindarajan; F J Hevia; R L Peters
Journal:  Cancer       Date:  1984-04-15       Impact factor: 6.860

7.  Significance of IgM antibody to hepatitis B core antigen in a Greek population with chronic hepatitis B virus infection.

Authors:  N C Tassopoulos; M H Sjogren; J R Ticehurst; R E Engle; A Roumeliotou-Karayannis; J L Gerin; R H Purcell; G Papaevangelou
Journal:  Liver       Date:  1986-10

8.  Immunoglobulin M antibody to hepatitis B core antigen in patients with chronic type B hepatitis.

Authors:  M Sjogren; J H Hoofnagle
Journal:  Gastroenterology       Date:  1985-08       Impact factor: 22.682

9.  Radioimmunoassay detection of IgM antibodies to the HBV-associated delta (delta) antigen:" clinical significance in delta infection.

Authors:  A Smedile; C Lavarini; O Crivelli; G Raimondo; M Fassone; M Rizzetto
Journal:  J Med Virol       Date:  1982       Impact factor: 2.327

10.  Mortality of hepatitis B positive blood donors in England and Wales.

Authors:  A J Hall; P D Winter; R Wright
Journal:  Lancet       Date:  1985-01-12       Impact factor: 79.321

View more
  1 in total

Review 1.  Hepatitis D and hepatocellular carcinoma.

Authors:  Zaigham Abbas; Minaam Abbas; Sarim Abbas; Lubna Shazi
Journal:  World J Hepatol       Date:  2015-04-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.